Related Experiment Video
Updated: May 16, 2025

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
Published on: June 7, 2019
Hypopigmented Junctional BAP1-Inactivated Melanocytoma: A Paradigm Shift
Ali Gunesch1, Iwei Yeh2, Timothy McCalmont3
1Oregon Health & Science University, School of Medicine, Portland, Oregon, USA.
Abstract:
Since their original description by Wiesner et al., the spectrum of clinical, histopathologic, and molecular findings of BAP1 (BRCA1-associated protein 1)-inactivated melanocytomas has been more fully characterized. Herein, we report an exceptional presentation of multiple junctional melanocytic BAP1-inactivated melanocytomas with a clinically hypopigmented appearance in a patient. Targeted DNA sequencing demonstrated the same BAP1 frameshift mutation (BAP1 p.R59f) in three different lesions. One of the specimens also displayed two truncating mutations in NF1 (NF1 p.Q129* and NF1 p.Q1801*) at 8%-9% mutant allele frequency. To our knowledge, BIM confined entirely to the epidermis, and multiple BIMs presenting in hypopigmented fashion have not been widely reported previously.
Insights
This study details a rare case of multiple BAP1-inactivated melanocytomas with hypopigmented features. Genetic analysis revealed identical BAP1 mutations across lesions, with one also showing NF1 mutations.
Area of Science:
- Dermatopathology
- Oncology
- Genetics
Background:
- BRCA1-associated protein 1 (BAP1)-inactivated melanocytomas are increasingly characterized.
- Previous reports have not widely documented multiple BAP1-inactivated melanocytomas presenting with hypopigmentation.
Related Concept Videos
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
The Intrinsic Apoptotic Pathway

